The American Journal of Medicine
Volume 118, Issue 6 , Pages 592-603 , June 2005

Spondyloarthritis: update on pathogenesis and management

  • John D. Reveille, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to: John D. Reveille, MD, The University of Texas-Houston Health Science Center, MSB 5.270, 6431 Fannin, Houston, TX 77030.
    • ,
  • Frank C. Arnett, MD

References 

  1. Arnett FC . Seronegative spondyloarthropathies . In:  Dale DC ,  Federman DD editor. ACP Medicine, 2004–2005 . New York: Web MD; 2004;p. 1350–1361
  2. van der Linden SJ , van der Heijde D . Spondylarthopathies (ankylosing spondylitis) . In:  Ruddy S ,  Harris ED ,  Sledge CB editor. Kelley’s Textbook of Rheumatology . 6th ed.. Philadelphia: WB Saunders; 2000;p. 1039–1053
  3. Martin TM , Smith JR , Rosenbaum JT . Anterior uveitis (current concepts of pathogenesis and interactions with spondyloarthopathies) . Curr Opin Rheumatol. . 2002;14:337–341
  4. Bergfeldt L . HLA-B27-associated cardiac disease . Ann Intern Med. . 1997;127:621–629
  5. Brown MA , Laval SH , Brophy S , Calin A . Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis . Ann Rheum Dis. . 2000;59:883–886
  6. Brown MA , Kennedy LG , MacGregor AJ , et al.   Susceptibility to ankylosing spondylitis in twins (the role of genes, HLA, and the environment) . Arthritis Rheum. . 1997;40:1823–1828
  7. Allen RL , Raine T , Haude A , et al.   Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures . J Immunol. . 2001;167:5543–5547
  8. Brown MA , Wordsworth BP , Reveille JD . Genetics of ankylosing spondylitis . Clin Exp Rheumatol. . 2002;20(6 Suppl 28):S43–S49
  9. Ekman P , Kirveskari J , Granfors K . Modification of disease outcome in Salmonella-infected patients by HLA-B27 . Arthritis Rheum. . 2000;43:1527–1534
  10. Reveille JD , Ball EJ , Khan MA . HLA-B27 and genetic predisposing factors in spondyloarthropathies . Curr Opin Rheumatol. . 2001;13:265–272
  11. Mody GM , Parke FA , Reveille JD . Articular manifestations of human immunodeficiency virus infection . Best Pract Res Clin Rheumatol. . 2003;17:265–287
  12. Montserrat V , Marti M , Lopez de Castro JA . Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis . J Immunol. . 2003;170:5778–5785
  13. Hillig RC , Hulsmeyer M , Saenger W , et al.   Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association . J Biol Chem. . 2004;279:652–653
  14. Hulsmeyer M , Fiorillo MT , Bettosini F , et al.   Dual, HLA-B27 subtype-dependent conformation of a self-peptide . J Exp Med. . 2004;199:271–281
  15. Dangoria NS , DeLay ML , Kingsbury DJ , et al.   HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum . J Biol Chem. . 2002;277:23459–23468
  16. Bird LA , Peh CA , Kollnberger S , et al.   Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling . Eur J Immunol. . 2003;33:748–759
  17. Kollnberger S , Bird L , Sun MY , et al.   Cell-surface expression and immune receptor recognition of HLA-B27 homodimers . Arthritis Rheum. . 2002;46:2972–2982
  18. Kuon W , Holzhutter HG , Appel H , et al.   Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases . J Immunol. . 2001;167:4738–4746
  19. Fiorillo MT , Maragno M , Butler R , et al.   CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis . J Clin Invest. . 2000;106:47–53
  20. Dulphy N , Peyrat MA , Tieng V , et al.   Common intra-articular T cell expansions in patients with reactive arthritis (identical beta-chain junctional sequences and cytotoxicity toward HLA-B27) . J Immunol. . 1999;162:3830–3839
  21. Ekman P , Saarinen M , He Q , et al.   HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines . Infect Immun. . 2002;70:1609–1614
  22. Inman RD , Payne U . Determinants of synoviocyte clearance of arthritogenic bacteria . J Rheumatol. . 2003;30:1291–1297
  23. Boyle LH , Goodall JC , Opat SS , Gaston JS . The recognition of HLA-B27 by human CD4(+) T lymphocytes . J Immunol. . 2001;167:2619–2624
  24. van der Linden SM , Valkenburg HA , de Jongh BM , Cats A . The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population . Arthritis Rheum. . 1984;27:241–249
  25. Brown MA , Kennedy LG , Darke C , et al.   The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis . Arthritis Rheum. . 1998;41:460–465
  26. Said-Nahal R , Miceli-Richard C , Gautreau C , et al.   The role of HLA genes in familial spondyloarthropathy (a comprehensive study of 70 multiplex families) . Ann Rheum Dis. . 2002;61:201–206
  27. Singal DP , Li J , Zhang G . Microsatellite polymorphism of the MICA gene and susceptibility to rheumatoid arthritis . Clin Exp Rheumatol. . 2001;19:451–452
  28. Gonzalez S , Torre-Alonso JC , Martinez-Borra J , et al.   TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients . J Rheumatol. . 2001;28:1288–1293
  29. Hohler T , Schaper T , Schneider PM , et al.   Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals . Arthritis Rheum. . 1998;41:1489–1492
  30. Vargas-Alarcon G , Londono JD , Hernandez-Pacheco G , et al.   Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies . Ann Rheum Dis. . 2002;61:48–51
  31. Fraile A , Collado MD , Mataran L , et al.   TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis . Exp Clin Immunogene. . 2000;17:199–204
  32. Maksymowych WP , Tao S , Vaile J , et al.   LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis . J Rheumatol. . 2000;27:183–189
  33. Murray C , Mann DL , Gerber LN , et al.   Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex . J Clin Invest. . 1980;66:670–675
  34. Orchard TR , Thiyagaraja S , Welsh KI , et al.   Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease . Gastroenterology. . 2000;118:274–278
  35. Laval SH , Timms A , Edwards S , et al.   Whole-genome screening in ankylosing spondylitis (evidence of non-MHC genetic-susceptibility loci) . Am J Hum Genet. . 2001;68:918–926
  36. Monowarul Islam SM , Numaga J , Fujino Y , et al.   HLA-DR8 and acute anterior uveitis in ankylosing spondylitis . Arthritis Rheum. . 1995;38:547–550
  37. Zhang G , Luo J , Bruckel J , et al.   Genetic studies in familial ankylosing spondylitis susceptibility . Arthritis Rheum. . 2004;50:2246–2254
  38. Miceli-Richard C , Zouali H , Said-Nahal R , et al.   Significant linkage to spondyloarthropathy on 9q31–34 . Hum Mol Genet. . 2004;13:1641–1648
  39. Nair RP , Stuart P , Henseler T , et al.   Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C . Am J Hum Genet. . 2000;66:1833–1844
  40. Tomfohrde J , Silverman A , Barnes R , et al.   Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q . Science. . 1994;264:1141–1145
  41. Becker KG , Simon RM , Bailey-Wilson JE , et al.   Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases . Proc Natl Acad Sci (USA). . 1998;95:9979–9984
  42. Rahman P , Bartlett S , Siannis F , et al.   CARD15 (a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis) . Am J Hum Genet. . 2003;73:677–681
  43. Hugot J-P , Laurent-Puig P , Gower-Rousseau C , et al.   Mapping of a susceptibility locus for Crohn’s disease on chromosome 16 . Nature (London). . 1996;379:821–823
  44. Bonen DK , Cho JH . The genetics of inflammatory bowel disease . Gastroenterology. . 2003;124:521–536
  45. Crane AM , Bradbury L , van Heel DA , et al.   Role of NOD2 variants in spondylarthritis . Arthritis Rheum. . 2002;46:1629–1633
  46. Miceli-Richard C , Zouali H , et al.   CARD15/NOD2 analyses in spondylarthropathy . Arthritis Rheum. . 2002;46:1405–1406
  47. Beyeler C , Armstrong M , Bird HA , et al.   Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis . Ann Rheum Dis. . 1996;55:66–68
  48. Brown MA , Edwards S , Hoyle E , et al.   Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis . Hum Mol Genet. . 2000;9:1563–1566
  49. Timms AE , Crane AM , Sims AM , et al.   The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis . Am J Hum Genet. . 2004;75:587–595
  50. McGarry F , Neilly J , Anderson N , et al.   A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis . Rheumatology (Oxford). . 2001;40:1359–1364
  51. van der Paardt M , Crusius JB , Garcia-Gonzalez MA , et al.   Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis . Rheumatology (Oxford). . 2002;41:1419–1423
  52. Maksymowych WP , Reeve J , Reveille JD , et al.   High throughput single nucleotide polymorphism (SNP) analysis of the interleukin-1 receptor antagonist (IL-1 RN) locus in patients with ankylosing spondylitis (AS) by MALDI-TOF mass spectroscopy . Arthritis Rheum. . 2003;48:2011–2018
  53. Jin L , Zhang G , Akey JM , et al.   Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility . Arthritis Rheum. . 2004;50:3047–3048
  54. Tsui FW , Tsui HW , Cheng EY , et al.   Novel genetic markers in the 5’-flanking region of ANKH are associated with ankylosing spondylitis . Arthritis Rheum. . 2003;48:791–797
  55. Timms AE , Zhang Y , Bradbury L , et al.   Investigation of the role of ANKH in ankylosing spondylitis . Arthritis Rheum. . 2003;48:2898–2902
  56. Mori K , Ushiyama T , Inoue K , Hukuda S . Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis . Rheumatology (Oxford). . 2000;39:530–532
  57. Collado-Escobar MD , Nieto A , Mataran L , et al.   Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis . J Rheumatol. . 2000;27:1461–1463
  58. Goedecke V , Crane AM , Jaakkola E , et al.   Interleukin 10 polymorphisms in ankylosing spondylitis . Genes Immun. . 2003;4:74–76
  59. Howe HS , Cheung PL , Kong KO , et al.   Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis . Rheumatology (Oxford). . 2005;44:51–54
  60. Balding J , Kane D , Livingstone W , et al.   Cytokine gene polymorphisms (association with psoriatic arthritis susceptibility and severity) . Arthritis Rheum. . 2003;48:1408–1413
  61. Brown MA , Brophy S , Bradbury L , et al.   Identification of major loci controlling clinical manifestations of ankylosing spondylitis . Arthritis Rheum. . 2003;48:2234–2239
  62. Khan MA . Update on spondyloarthropathies . Ann Intern Med. . 2002;136:896–907
  63. Nikkari S , Rantakokko K , Ekman P , et al.   Salmonella-triggered reactive arthritis (use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid) . Arthritis Rheum. . 1999;42:84–89
  64. Gerard HC , Branigan PJ , Schumacher HR , Hudson AP . Synovial chlamydia trachomatis in patients with reactive arthritis/Reiter’s syndrome are viable but show aberrant gene expression . J Rheumatol. . 1998;25:734–742
  65. Schumacher HR , Arayssi T , Crane M , et al.   Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects . Arthritis Rheum. . 1999;42:1281–1284
  66. Cowling P , Ebringer R , Ebringer A . Association of inflammation with raised serum IgA in ankylosing spondylitis . Ann Rheum Dis. . 1980;39:545–549
  67. Stone MA , Payne U , Schentag C , et al.   Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis . Rheumatology (Oxford). . 2004;43:148–155
  68. Stebbings S , Munro K , Simon MA , et al.   Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis . Rheumatology (Oxford). . 2002;41:1395–1401
  69. Cassandra M , Conte E , Cortez B . Childhood pustular psoriasis elicited by the streptococcal antigen (a case report and review of the literature) . Pediatr Dermatol. . 2003;20:506–510
  70. Mielants H , Veys EM , Goemaere S , et al.   Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology: a prospective study . J Rheumatol. . 1991;18:1542–1551
  71. Leirisalo-Repo M , Turunen U , Stenman S , et al.   High frequency of silent inflammatory bowel disease in spondylarthropathy . Arthritis Rheum. . 1994;37:23–31
  72. Martinez-Gonzalez O , Cantero-Hinojosa J , Paule-Sastre P , et al.   Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives . Br J Rheumatol. . 1994;33:644–647
  73. van der Heijde D , Bellamy N , Calin A , et al.   Preliminary core sets for endpoints in ankylosing spondylitis (assessments in Ankylosing Spondylitis Working Group) . J Rheumatol. . 1997;24:2225–2229
  74. Garrett S , Jenkinson TR , Kennedy LG , et al.   A new approach to defining disease status in ankylosing spondylitis. The Bath ankylosing spondylitis disease activity index . J Rheumatol. . 1994;21:2286–2291
  75. Calin A , Garrett S , Whitelock HC , et al.   A new approach to defining functional ability in ankylosing spondylitis. The Bath ankylosing spondylitis functional index . J Rheumatol. . 1994;21:2281–2285
  76. Daltroy LH , Larson MG , Roberts NW , Liang MH . A modification of the Health Assessment Questionnaire for the spondyloarthropathies . J Rheumatol. . 1990;17:946–950
  77. Jenkinson TR , Mallorie PA , Whitelock HC , et al.   Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index . J Rheumatol. . 1994;21:1694–1698
  78. Ware JE , Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection . Med Care. . 1992;30:473–483
  79. Haywood KL , Garratt AM , Jordan K , et al.   Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis (reliability, validity and responsiveness) . Rheumatology (Oxford). . 2002;41:1295–1302
  80. MacKay K , Mack C , Brophy S , Calin A . The Bath ankylosing spondylitis radiology index (BASRI) (a new validated approach to disease assessment) . Arthritis Rheum. . 1998;41:665–669
  81. Wanders AJ , Landewe RB , Spoorenberg A , et al.   What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter . Arthritis Rheum. . 2004;50:2622–2632
  82. Braun J , Baraliakos X , Golder W , et al.   Improvement of spinal inflammation in ankylosing spondylitis (AS) by infliximab therapy as assessed by magnetic resonance imaging (MRI) using a novel evaluated spinal scoring system . Arthritis Rheum. . 2003;48:1126–1136
  83. Uhrin Z , Kuzis S , Ward MM . Exercise and changes in health status in patients with ankylosing spondylitis . Arch Intern Med. . 2000;160:2969–2975
  84. Dagfinrud H , Hagen K . Physiotherapy interventions for ankylosing spondylitis . Cochrane Database Syst Rev . 2001; CD002822
  85. Dougados M , van der Linden S , Leirisalo-Repo M , et al.   Sulfasalazine in the treatment of spondylarthropathy (a randomized, multicenter, double-blind, placebo-controlled study) . Arthritis Rheum. . 1995;38:618–627
  86. Clegg DO , Reda DJ , Abdellatif M . Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies (a Department of Veterans Affairs cooperative study) . Arthritis Rheum. . 1999;42:2325–2329
  87. Taggart A , Gardiner P , McEnvoy F , et al.   Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized controlled study . Arthritis Rheum. . 1996;39:1400–1405
  88. Creemers MC , Franssen MJ , van de Putte LB , et al.   Methotrexate in severe ankylosing spondylitis (an open study) . J Rheumatol. . 1995;22:1104–1107
  89. Altan L , Bingol U , Karakoc Y , et al.   Clinical investigation of methotrexate in the treatment of ankylosing spondylitis . Scand J Rheumatol. . 2001;30:255–259
  90. Maugars Y , Mathis C , Berthelot JM , et al.   Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies (a double-blind study) . Br J Rheumatol. . 1996;35:767–770
  91. Lauhio A , Leirisalo-Repo M , Lahdevirta J , et al.   Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis . Arthritis Rheum. . 1991;34:6–14
  92. Laasila K , Laasonen L , Leirisalo-Repo M . Antibiotic treatment and long term prognosis of reactive arthritis . Ann Rheum Dis. . 2003;62:655–658
  93. Yli-Kerttula T , Luukkainen R , Yli-Kerttula U , et al.   Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis . Ann Rheum Dis. . 2003;62:880–884
  94. Maksymowych WP , Lambert R , Jhangri GS , et al.   Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy . J Rheumatol. . 2001;28:144–155
  95. Huang F , Gu J , Zhao W , et al.   One-year open-label trial of thalidomide in ankylosing spondylitis . Arthritis Rheum. . 2002;47:249–254
  96. Brandt J , Haibel H , Cornely D , et al.   Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab . Arthritis Rheum. . 2000;43:1346–1352
  97. Braun J , Brandt J , Listing J , et al.   Two-year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis . Ann Rheum Dis. . 2005;64:229–234
  98. De Rycke L , Kruithof E , Van Damme N , et al.   Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy . Arthritis Rheum. . 2003;48:1015–1023
  99. Gorman J , Sack KE , Davis JC . Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α . N Engl J Med. . 2002;346:1349–1356
  100. Davis J , Webb A , Lund S , Sack K . Results from an open-label extension study of etanercept in ankylosing spondylitis . Arthritis Rheum. . 2004;51:302–304
  101. Marzo-Ortega H , McGonagle D , O’Connor P , Emery P . Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy (a clinical and magnetic resonance imaging study) . Arthritis Rheum. . 2001;44:2112–2117
  102. Mease PJ , Goffe BS , Metz J , et al.   Etanercept in the treatment of psoriatic arthritis and psoriasis (a randomised trial) . Lancet. . 2000;356:385–390
  103. Smith JR , Levinson RD , Holland GN , et al.   Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease . Arthritis Rheum. . 2001;45:252–257
  104. Braun J , Pham T , Sieper J , et al.   International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis . Ann Rheum Dis. . 2003;62:817–824
  105. Obermayer-Pietsch BM , Lange U , Tauber G , et al.   Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis . Osteoporos Int. . 2003;14:995–1000
  106. Maillefert JF , Aho LS , El Maghraoui A , et al.   Changes in bone density in patients with ankylosing spondylitis (a two-year follow-up study) . Osteoporos Int. . 2001;12:605–609
  107. Lange U , Jung O , Teichmann J , Neeck G . Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis . Osteoporos Int. . 2001;12:1031–1035
  108. Demis E , Roux C , Breban M , Dougados M . Infliximab in spondylarthropathy-influence on bone density . Clin Exp Rheumatol. . 2002;20(6 Suppl 28):S185–S186
  109. Sweeney S , Gupta R , Taylor G , Calin A . Total hip arthroplasty in ankylosing spondylitis (outcome in 340 patients) . J Rheumatol. . 2001;28:1862–1866
  110. Brinker MR , Rosenberg AG , Kull L , Cox DD . Primary noncemented total hip arthroplasty in patients with ankylosing spondylitis (clinical and radiographic results at an average follow-up period of 6 years) . J Arthroplasty. . 1996;11:802–812
  111. Mitra D , Elvins DM , Speden DJ , Collins AJ . The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density . Rheumatology (Oxford). . 2000;39:85–89
  112. Van Royen BJ , De Gast A . Lumbar osteotomy for correction of thoracolumbar kyphotic deformity in ankylosing spondylitis (a structured review of three methods of treatment) . Ann Rheum Dis. . 1999;58:399–406
  113. Ward MM , Kuzis S . Ceiling effects and the Schober test . J Rheumatol. . 2003;30:2732–2733
  114. Sahin G , Calikoglu M , Ozge C , et al.   Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis . Clin Rheumatol. . 2004;23:199–202
  115. Heuft-Dorenbosch L , Vosse D , Landewe R , et al.   Measurement of spinal mobility in ankylosing spondylitis (comparison of occiput-to-wall and tragus-to-wall distance) . J Rheumatol. . 2004;31:1779–1784
  116. Ezquerra A , Bragado R , Vega MA , et al.   Primary structure of papain-solubilized human histocompatibility antigen HLA-B27 . Biochemistry. . 1985;254:1733–1741

PII: S0002-9343(05)00002-1

doi: 10.1016/j.amjmed.2005.01.001

The American Journal of Medicine
Volume 118, Issue 6 , Pages 592-603 , June 2005

Article Tools

* Image Usage & Resolution